Search for: "AMGEN INC."
Results 221 - 240
of 704
Sorted by Relevance
|
Sort by Date
13 Mar 2013, 5:23 am
In Amgen Inc. v. [read post]
28 Jun 2007, 1:03 pm
Amgen, Inc. by the Sixth Circuit in March 2006. [read post]
Guidance Software to Demonstrate New State-of-the-Art EnCase(R) eDiscovery Capabilities at LegalTech
17 Jan 2008, 12:00 pm
., Jan 17, 2008 (BUSINESS WIRE) — Guidance Software Inc. [read post]
29 Jul 2014, 12:08 pm
The reference product, Neupogen®, which brought maker Amgen Inc. $1.4 billion in sales in 2013, is a biologic used […] [read post]
23 Oct 2015, 2:58 pm
Robinson in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
28 Feb 2013, 8:13 am
While it is clear that Amgen is an important decision for securities fraud cases, we expect it to impact future class actions in general. [read post]
27 Jun 2023, 7:32 pm
Cir. 2023)Amgen Inc. v. [read post]
11 Jul 2012, 5:53 am
Despite denying any wrongdoing, Denver-based Davita Inc., a kidney dialysis chain, has settled a Texas lawsuit related to its use of Epogen, an anemic drug made by Amgen. [read post]
21 Jun 2016, 1:38 pm
Amgen Inc., et al., No. 15-1039 (petition for writ of ceritorari filed February 16, 2016; 4 briefs filed in support); and Amgen Inc., et al. v. [read post]
16 Feb 2021, 7:57 pm
Inc., 959 F.3d 1091 (Fed. [read post]
1 Mar 2013, 7:55 am
In its ruling on February 27, in Amgen, Inc. v. [read post]
15 Jun 2017, 10:00 pm
Amgen Inc., which involved a case emerging out of the Biologics Price Competition and Innovation Act. [read post]
14 Feb 2020, 12:00 pm
Amgen, Inc., Civil Action No. 17-1407-CFC, Consol. [read post]
30 Mar 2009, 7:39 pm
A gene is, in one way of looking at it, "but a chemical compound, albeit a complex one," and this view of the gene's nature has informed the emphasis on "structure, structure, structure" taken by the Federal Circuit from Amgen Inc. v. [read post]
